{
  "actions": [
    {
      "acted_at": "2000-09-20", 
      "references": [
        {
          "reference": "CR E1538", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2000-09-20", 
      "committee": "Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-09-20", 
      "committee": "House Commerce", 
      "references": [], 
      "text": "Referred to House Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-09-20", 
      "committee": "House Judiciary", 
      "references": [], 
      "text": "Referred to House Judiciary", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-10-20", 
      "in_committee": "House Commerce", 
      "references": [], 
      "subcommittee": "Health and Environment", 
      "text": "Referred to the Subcommittee on Health and Environment.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5235-106", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health and Environment", 
      "subcommittee_id": "04"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }
  ], 
  "congress": "106", 
  "cosponsors": [
    {
      "district": "1", 
      "name": "Berry, Marion", 
      "sponsored_at": "2000-09-20", 
      "state": "AR", 
      "thomas_id": "01462", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "13", 
      "name": "Brown, Sherrod", 
      "sponsored_at": "2000-09-20", 
      "state": "OH", 
      "thomas_id": "00136", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "2", 
      "name": "Coburn, Tom A.", 
      "sponsored_at": "2000-09-20", 
      "state": "OK", 
      "thomas_id": "00212", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "20", 
      "name": "Deutsch, Peter", 
      "sponsored_at": "2000-09-20", 
      "state": "FL", 
      "thomas_id": "00291", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "13", 
      "name": "Stark, Fortney Pete", 
      "sponsored_at": "2000-09-20", 
      "state": "CA", 
      "thomas_id": "01101", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2000-09-20", 
  "number": "5235", 
  "official_title": "To ensure the timely availability of generic drugs through enhancement of drug approval and antitrust laws enforced by the Food and Drug Administration and the Federal Trade Commission regarding brand name drugs and generic drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Prescription Drug Competition Act of 2000", 
  "sponsor": {
    "district": "29", 
    "name": "Waxman, Henry A.", 
    "state": "CA", 
    "thomas_id": "01209", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2000-09-20", 
  "subjects": [
    "Actions and defenses", 
    "Commerce", 
    "Contracts", 
    "Drug industry", 
    "Drugs", 
    "Fines (Penalties)", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Injunctions", 
    "Law", 
    "Prescription pricing", 
    "Restrictive trade practices"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2000-09-20", 
    "text": "Prescription Drug Competition Act of 2000 - Requires a brand name drug company and a generic drug applicant that enter into an agreement regarding the sale or manufacture of a generic drug determined or likely to be the therapeutic equivalent of such brand name drug, when such agreement could limit the research, development, manufacture, marketing, or sale of such generic drug, to file with the Federal Trade Commission and the Secretary of Health and Human Services the text of such agreement and an explanation of whether such agreement could delay, restrain, limit, or otherwise interfere with the production, manufacture, or sale of the generic drug in question. Requires such filing within ten days of agreement execution. Provides civil penalties for violation."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug Competition Act of 2000", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To ensure the timely availability of generic drugs through enhancement of drug approval and antitrust laws enforced by the Food and Drug Administration and the Federal Trade Commission regarding brand name drugs and generic drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-14T18:55:10-04:00"
}